These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1068776)
1. [How and why does cancer develop? (3) Answers--open questions]. Goerttler K Dtsch Zahnarztl Z; 1976 Oct; 31(10):750-3. PubMed ID: 1068776 [No Abstract] [Full Text] [Related]
2. [Problems and possibilities of experimental cancer research]. Sachsenmaier W Osterr Z Erforsch Bekampf Krebskr; 1972; 27(3):149-58. PubMed ID: 5068525 [No Abstract] [Full Text] [Related]
3. Cancer chemotherapy: a guide for nurses. Biochemistry and pharmacology. Thomson L Nurs Times; 1979 Sep; 75(39):suppl 13-6. PubMed ID: 258356 [No Abstract] [Full Text] [Related]
5. [Current emphasis in experimental cancer research and its relation to clinical oncology]. Seeber S Onkologie; 1986 Oct; 9 Suppl 2():14, 17-9. PubMed ID: 3534669 [No Abstract] [Full Text] [Related]
6. Why do immunosuppressed patients develop cancer? Penn I Crit Rev Oncog; 1989; 1(1):27-52. PubMed ID: 2488123 [No Abstract] [Full Text] [Related]
7. Effects of chemotherapy on the incorporation of 3 H-thymidine into DNA of human neoplastic tissue. Sky-Peck HH Natl Cancer Inst Monogr; 1971 Dec; 34():197-203. PubMed ID: 5140863 [No Abstract] [Full Text] [Related]
8. DNA and its associated processes as targets for cancer therapy. Hurley LH Nat Rev Cancer; 2002 Mar; 2(3):188-200. PubMed ID: 11990855 [TBL] [Abstract][Full Text] [Related]
9. Cancer chemotherapeutic agents. Krakoff IH CA Cancer J Clin; 1973; 23(4):209-19. PubMed ID: 4200099 [No Abstract] [Full Text] [Related]
10. Drug-DNA interactions: new discoveries and possibilities for cancer treatment. Souhami RL Q J Med; 1994 Apr; 87(4):195-7. PubMed ID: 8208908 [No Abstract] [Full Text] [Related]
11. [Testing the sensitivity of malignant tumors to cytostatics in vitro and in vivo. Methods and clinical experiences]. Wüst GP Munch Med Wochenschr; 1973 May; 115(18):839-42. PubMed ID: 4800216 [No Abstract] [Full Text] [Related]
13. [Resistance to cytostatic drugs]. Elonen E Duodecim; 1998; 114(13):1319-28. PubMed ID: 11552258 [No Abstract] [Full Text] [Related]
14. NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Shen HM; Tergaonkar V Apoptosis; 2009 Apr; 14(4):348-63. PubMed ID: 19212815 [TBL] [Abstract][Full Text] [Related]
15. The resting cell: a chemotherapeutic problem. Part I. Sarna G Biomedicine; 1974 Sep; 20(5):322-6. PubMed ID: 4451696 [No Abstract] [Full Text] [Related]
16. Kinetic behavior versus response to chemotherapy. Skipper HE Natl Cancer Inst Monogr; 1971 Dec; 34():2-14. PubMed ID: 4946581 [No Abstract] [Full Text] [Related]
17. The growth kinetics of tumors in relation to their therapeutic response. Steel GG Laryngoscope; 1975 Feb; 85(2):359-70. PubMed ID: 1089861 [No Abstract] [Full Text] [Related]
19. Cancer. DNA damage, deamidation, and death. Li C; Thompson CB Science; 2002 Nov; 298(5597):1346-7. PubMed ID: 12434041 [No Abstract] [Full Text] [Related]
20. [Novel targets for cancer chemotherapy]. Inoue S Gan To Kagaku Ryoho; 1996 Jan; 23(2):191-201. PubMed ID: 8611047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]